An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024Michael R. Ardern‐Jones, M.F. Mohd Mustapa, Philip Laws et al.|British Journal of Dermatology|2024Cited by 28
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin typesAngela L. Bosma, Maritza A. Middelkamp‐Hup, Wouter Ouwerkerk et al.|JAAD International|2022Cited by 10
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L. Bosma, Phyllis I. Spuls, Louise A. A. Gerbens et al.|Journal of Dermatological Treatment|2023Cited by 5
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L. Bosma, Phyllis I. Spuls, Hajar El Khattabi et al.|Research Portal (King's College London)|2023Cited by 0